Purchases and Sales Made in Q3 2020 in Timber Pharmaceuticals, Inc. (TMBR)
This table provides information about the institutional ownership of Timber Pharmaceuticals, Inc. (TMBR) during Q3 2020. The information is specifically focused on institutions that hold shares of Timber Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 16, 2020
Q3 2020
|
Bridgeway Capital Management, LLC
Houston, TX |
BUY
|
- |
158KNew |
$146K - $380K
|
158K
$0
|
|
Nov 16, 2020
Q3 2020
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
14.8KNew |
$13.6K - $35.4K
|
14.8K
$0
|
|
Dec 11, 2020
Q3 2020
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
10.9KNew |
$10K - $26.1K
|
10.9K
$0
|
|
Nov 16, 2020
Q3 2020
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
942New |
$867 - $2.26K
|
942
$0
|
|
Nov 05, 2020
Q3 2020
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
29+ 322.22% |
$26.7 - $69.6
|
38
$0
|
|
Nov 13, 2020
Q3 2020
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 12, 2020
Q3 2020
|
Pathstone Family Office, LLC
Englewood, NJ |
SELL
|
- |
-75Closed |
$69 - $180
|
0
$0
|
|
Nov 12, 2020
Q3 2020
|
Ubs Group Ag
|
SELL
|
- |
-1.06K- 22.68% |
$977 - $2.55K
|
3.62K
$0
|
|
Nov 12, 2020
Q3 2020
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-53.7KClosed |
$49.4K - $129K
|
0
$0
|